AAAAAA

   
Results: 1-15 |
Results: 15
Impact of serum basic fibroblast growth factor on prognosis in human renalcell carcinoma
Authors: Rasmuson, T Grankvist, K Jacobsen, J Ljungberg, B
Citation: T. Rasmuson et al., Impact of serum basic fibroblast growth factor on prognosis in human renalcell carcinoma, EUR J CANC, 37(17), 2001, pp. 2199-2203
Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport
Authors: Behnam-Motlagh, P Sandstrom, PE Henriksson, R Grankvist, K
Citation: P. Behnam-motlagh et al., Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport, PHARM TOX, 88(5), 2001, pp. 244-249
Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma
Authors: Rasmuson, T Ljungberg, B Grankvist, K Jacobsen, J Olsson, T
Citation: T. Rasmuson et al., Increased serum cortisol levels are associated with high tumour grade in patients with renal cell carcinoma, ACTA ONCOL, 40(1), 2001, pp. 83-87
Cisplatin-induced apoptosis of mesothelioma cells is affected by potassiumion flux modulator amphotericin B and bumetanide
Authors: Marklund, L Henriksson, R Grankvist, K
Citation: L. Marklund et al., Cisplatin-induced apoptosis of mesothelioma cells is affected by potassiumion flux modulator amphotericin B and bumetanide, INT J CANC, 93(4), 2001, pp. 577-583
Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone
Authors: Seippel, L Eriksson, O Grankvist, K von Shoultz, B Backstrom, T
Citation: L. Seippel et al., Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone, GYNECOL END, 14(3), 2000, pp. 173-181
Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment
Authors: Linderholm, B Grankvist, K Wilking, N Johansson, M Tavelin, B Henriksson, R
Citation: B. Linderholm et al., Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment, J CL ONCOL, 18(7), 2000, pp. 1423-1431
Response in shape and size of individual P31 cancer cells to cisplatin andouabain: A computerized image analysis of cell halo characteristics duringcontinuous perfusion
Authors: Behnam-Motlagh, P Grankvist, K Henriksson, R Engstrom, KG
Citation: P. Behnam-motlagh et al., Response in shape and size of individual P31 cancer cells to cisplatin andouabain: A computerized image analysis of cell halo characteristics duringcontinuous perfusion, CYTOMETRY, 40(3), 2000, pp. 198-208
Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+,K+, 2Cl(-)-cotransport blocker bumetanide
Authors: Marklund, L Henriksson, R Grankvist, K
Citation: L. Marklund et al., Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+,K+, 2Cl(-)-cotransport blocker bumetanide, LIFE SCI, 66(23), 2000, pp. PL319-PL324
Vascular endothelial growth factor as prognostic factor in renal cell carcinoma
Authors: Jacobsen, J Rasmuson, T Grankvist, K Ljungberg, S
Citation: J. Jacobsen et al., Vascular endothelial growth factor as prognostic factor in renal cell carcinoma, J UROL, 163(1), 2000, pp. 343-347
p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma
Authors: Linderholm, B Lindh, B Tavelin, B Grankvist, K Henriksson, R
Citation: B. Linderholm et al., p53 and vascular-endothelial-growth-factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma, INT J CANC, 89(1), 2000, pp. 51-62
Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation
Authors: Jonsson, OE Bjermer, L Denekamp, J Grankvist, K Henriksson, R
Citation: Oe. Jonsson et al., Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation, EUR J CANC, 35(8), 1999, pp. 1268-1273
Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells
Authors: Behnam-Motlagh, P Engstrom, KG Henriksson, R Grankvist, K
Citation: P. Behnam-motlagh et al., Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells, EUR J CANC, 35(1), 1999, pp. 145-153
Neuroendocrine differentiation in renal cell carcinoma - Evaluation of chromogranin a and neuron-specific enolase
Authors: Rasmuson, T Grankvist, K Roos, G Ljungberg, B
Citation: T. Rasmuson et al., Neuroendocrine differentiation in renal cell carcinoma - Evaluation of chromogranin a and neuron-specific enolase, ACTA ONCOL, 38(5), 1999, pp. 623-628
Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?
Authors: Linderholm, B Tavelin, B Grankvist, K Henriksson, R
Citation: B. Linderholm et al., Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer?, BR J CANC, 81(4), 1999, pp. 727-732
Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity
Authors: Jonsson, O Behnam-Motlagh, P Persson, M Henriksson, R Grankvist, K
Citation: O. Jonsson et al., Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity, BIOCH PHARM, 58(11), 1999, pp. 1801-1806
Risultati: 1-15 |